Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high- density lipoprotein cholesterol.
L’ étude VA-HIT a été publiée par Rubins HB, Robins SJ, Collins D et coll. « Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol ».